Applied Genetic Technologies Corporation
AGTC · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $12,230 | $34,674 | $46,694 | $81,483 |
| - Cash | $34,241 | $46,366 | $67,849 | $72,771 |
| + Debt | $20,150 | $22,471 | $24,560 | $22,271 |
| Enterprise Value | -$1,861 | $10,779 | $3,405 | $30,983 |
| Revenue | $0 | $325 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | $0 | $325 | $0 | $0 |
| % Margin | – | 100% | – | – |
| EBITDA | -$17,344 | -$17,341 | -$13,248 | -$18,443 |
| % Margin | – | -5,335.7% | – | – |
| Net Income | $17,065 | -$18,972 | -$14,908 | -$18,437 |
| % Margin | – | -5,837.5% | – | – |
| EPS Diluted | 0.38 | -0.42 | -0.34 | -0.43 |
| % Growth | 190.5% | -23.5% | 20.9% | – |
| Operating Cash Flow | -$17,387 | -$18,258 | -$13,997 | $0 |
| Capital Expenditures | -$183 | -$860 | -$202 | -$821 |
| Free Cash Flow | -$17,570 | -$19,118 | -$14,199 | -$821 |